RxDoctor Payments Data

Sharon White-Findley, DO

Family Medicine · Pinckneyville, ILNPI 1790755692

Payments from drug & device makers

$2,315in general payments, 2019–2025

Across 89 payments — averaging $26.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$470
  • Amgen$338
  • Lilly USA, LLC$201
  • AstraZeneca$182
  • Otsuka America Pharmaceutical, Inc.$124
  • Novartis$119
  • plus $881 from 20 others

What the payments were for

  • Food & beverage$2,315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,315 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$2,104
Medicare patients
15
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate14$6,277
Gabapentin55$1,315
Duloxetine Hcl22$804
Omeprazole46$795
SynthroidLevothyroxine Sodium13$745
Rosuvastatin Calcium58$726
Albuterol Sulfate HfaAlbuterol Sulfate29$663
Potassium Chloride38$613
Levothyroxine Sodium61$567
Montelukast Sodium41$562
Lisinopril88$556
Atorvastatin Calcium76$542
Metoprolol Succinate29$469
Valsartan14$426
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$425

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$41$6,27714 claims
AbbVieSynthroid$40$74513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Pinckneyville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →